Remove Journal Remove San Diego Remove Startup Remove Venture Capital
article thumbnail

Xirrus Ranks Two In WSJ Top Startups List

socalTECH

In a proof that it's not all social media and e-commerce here in Southern California, number two ranking startup in The Wall Street Journal's ranking of the "Top 50 Startups" is none other than wireless hardware provider Xirrus , based in Thousand Oaks. That list included Laguna Hills-based Glaukos at number 7; Donuts Inc. ,

article thumbnail

Entrepreneurs Look to Angels and Micro-VCs for Cash

Xconomy

You don’t need me to tell you it’s a rough world out there for startups. Venture capitalists have been unusually stingy lately, hanging on to billions of dollars they’d typically be channeling into promising young companies. You could make a good case that these investors are taking the “venture” out of “venture capital.”

Angel 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More

Xconomy

In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. The figures come from the National Venture Capital Association and financial research firm Pitchbook.

article thumbnail

Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup

Xconomy

A key scientist involved in integrin research, Harvard University immunologist Tim Springer, is spinning out a biotech startup to develop a new generation of integrin-blocking drugs—pills instead of antibody-based injections—that he says will benefit from “a complete understanding” of these complex molecules.

Startup 40
article thumbnail

Pharma’s Productivity Problem: Finding More Blockbuster Drugs

Xconomy

A recent Wall Street Journal article that raised the possibility of Biogen as the target of another huge pharma buyout cited the lack of productivity as a major driver of M&A in the pharmaceutical industry. Yet despite relative plenty in the bio-venture community, pharma suffers from a shortage of drug candidates.

Product 40
article thumbnail

Pharmaceutical Price Controls Might Be Closer Than You Think

Xconomy

Charley Grant, writing in The Wall Street Journal , commented that, “Any action to curb price increases on older drugs would hurt manufacturers that rely on them to generate growth.” It has started.”

Pricing 40
article thumbnail

Tech Titans Peter Thiel, Matt Jacobson, Cameron and Tyler Winklevoss, Mich Mathews, Elon Musk Buy Homes in Los Angeles

SoCal Delicious

Professor Journal. Student Journal. Tech entrepreneurs and executives from Silicon Valley are moving south and buying up luxury homes in the Los Angeles area. He uses his former home, a just-under 900-square-foot beach bungalow two blocks away, to house Facebook employees visiting from up north. MarketWatch. MarketWatch.